Natus Medical’s Acquisition of Babybe GmbH

Oppenhoff advised Babybe GmbH on the transaction

Natus Medical Incorporated (NASDAQ:NTUS), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, executedd the acquisition of Babybe GmbH and its patented remote mother to baby communication technology. The Babybe technology will add to Natus’s market leading Newborn Care portfolio of products.

Babybe offers an innovative new way to remotely connect a mother and her baby in the neonatal intensive care unit (NICU). With this technology, mother and baby are connected in real time through heartbeat, breathing and vocal sounds using an active mattress system.

Clinical studies are currently underway to assess how the mother and baby connection impacts weight gain, apnea and neuro-development in premature newborns who are isolated in the NICU.

Oppenhoff advised Babybe GmbH with a team including Edder Cifuentes (Picture), Johannes Janning, Alf Baars, Simon Sawert, Marcel Markovic, Marc Krischer, Hanjo Prondzinski, Daniel Dohrn, Georg Lecheler and Cornelia-Cristina Scupra.

Involved fees earner: Alf Baars – Oppenhoff; Edder Cifuentes – Oppenhoff; Daniel Dohrn – Oppenhoff; Johannes Janning – Oppenhoff; Marc Krischer – Oppenhoff; Georg Lecheler – Oppenhoff; Marcel Markovic – Oppenhoff; Hanjo Prondzinski – Oppenhoff; Cornelia-Cristina Scupra – Oppenhoff;

Law Firms: Oppenhoff;

Clients: Babybe GmbH;